-
-
guilin pharmaceutical co., ltd.
spaq-co® disp
common name:sulfadoxine/pyrimethamine amodiaquine (hydrochloride) dispersible tablets
this product passed the who prequalification in 2018 and is the world's first drug for malaria prophylaxis in children approved for seasonal malaria chemoprevention (smc).
therapeutic area: prophylaxis for malaria.
-
-
guilin pharmaceutical co., ltd.
artesun®
common name:artesunate for injection
it is a global initiative and the "gold standard" for treatment of severe malaria. it passed the who prequalification in 2005, is the first-choice drug for severe malaria recommended by the who, and is known as an "anti-malarial miracle drug".
therapeutic area: treatment of severe malaria
-
-
shenyang hongqi pharmaceutical co., ltd.
pyrazinamide tablets
common name:pyrazinamide tablets
first-line anti-tb drug indicated for the treatment of tuberculosis in combination with other anti-tb drugs (such as streptomycin, isoniazid, rifampicin and ethambutol). a product passed consistency evaluation.
-
-
-
shenyang hongqi pharmaceutical co., ltd.
ethambutol hydrochloride tablets
common name:ethambutol hydrochloride tablets
first-line anti-tuberculosis drug indicated for the treatment of tuberculosis caused by mycobacterium tuberculosis in combination with other anti-tuberculosis drugs; also used for the treatment of tuberculous meningitis and atypical mycobacterial infections; a product passed consistency evaluation.
-
-
-
shenyang hongqi pharmaceutical co., ltd.
isoniazid tablets
common name:isoniazid tablets
first-line antituberculosis drug indicated for the treatment of various types of tb, including tuberculous meningitis and other mycobacterium tuberculosis infections. the first isoniazid product passed consistency evaluation.
-
-
-
shenyang hongqi pharmaceutical co., ltd.
protionamide enteric-coated tablets
common name:protionamide enteric-coated tablets
second-line antituberculous drug and the essential therapeutic drug for treatment of drug-resistant tuberculosis by inhibiting the cell wall synthesis of mycobacterium tuberculosis; a required drug for short-course regimen for treatment of drug-resistant tuberculosis.
-
-
-
shenyang hongqi pharmaceutical co., ltd.
rifampicin capsules
common name:rifampicin capsules
first-line drug for treatment of drug-susceptible tuberculosis; 0.3 g in strength, reduced number of tablets taken by patients and improved compliance; a product passed consistency evaluation.
-
-
-
shenyang hongqi pharmaceutical co., ltd.
fu he
common name:rifampicin capsules (ii)
first-line drug for treatment of drug-susceptible tuberculosis; rifampicin with less hepatic impairment and higher bioavailability; achieving the therapeutic effect of 0.6 g of general rifampicin with only two capsules per time.
-
-
-
shenyang hongqi pharmaceutical co., ltd.
rifampin and isoniazid tablets
common name:rifampin and isoniazid tablets
a drug recommended by who guidelines in standard treatment regimens for drug-susceptible tuberculosis; improved patient compliance; reduced drug resistance rate.
-
-
-
shenyang hongqi pharmaceutical co., ltd.
yi nuo ni kang
common name:ethambutol hydrochloride, pyrazinamide, rifampicin and isoniazid tablets (ii)
a drug recommended by who guidelines in standard treatment regimens for drug-susceptible tuberculosis; the only fixed-dose four-drug combination for tuberculosis treatment included in the who model lists of essential medicines; improved patient compliance; reduced drug resistance rate.
-
-
-
sichuan hexin pharmaceutical co., ltd.
xi chang/bi li shu
common name:cefmetazole sodium for injection
it has quality of brand name drug, and is a product under national medical insurance class b; a confidence choice for monotherapy of mixed infection of aerobic bacteria and anaerobic bacteria; simple choice for prevention of surgical infection and perioperative infection; economical choice for empirical therapy of infection of esbls-producing bacteria.
-
-
-
sichuan hexin pharmaceutical co., ltd.
赛复诺
common name:cefminox sodium for injection
it has quality of brand name drug, and is a product under national medical insurance class b; it is recommended by many guidelines and consensus at home and abroad; it has a broad antibacterial spectrum, covering g bacteria, g-bacteria and anaerobic bacteria; it has good stability against esbl enzymes, and has a low drug resistance rate clinically.
-
-
-
yaopharma co., ltd.
sha duo li ka
common name:potassium sodium dehydroandrographolide succinate for injection
it is an original product with high brand awareness and the highest market share; it is a chemical drug with simple component and clear structure; it is a lyophilized powder preparation, with good stability, facilitating storage, transportation and use; post-marketing safety reassessment of more than 30,000 cases confirms the high safety of the product.
-
-
jsk (suzhou) pharmaceutical co., ltd.
heptodin®
common name:lamivudine tablets
it is an original product under national medical insurance class b; it is the first oral anti-hbv drug marketed in china; it has high safety, has strong antiviral ability, and is a classic drug for patients with chronic hepatitis b; long-term treatment with it can effectively improve liver tissue inflammation and delay the progress of chronic hepatitis b disease.
-
-
clindamycin hydrochloride capsules
common name:瑞塞宁
it is a china's national essential drug under national medical insurance class a, and is included in the national centralized drug procurement list; it is recommended by multiple guidelines at home and abroad; it is an antibacterial drug for unrestricted use, and an experience choice for treatment of various common infections.
-